Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Other financing activities (2016 - 2025)

Historic Other financing activities for Option Care Health (OPCH) over the last 15 years, with Q3 2025 value amounting to $951000.0.

  • Option Care Health's Other financing activities fell 5480.04% to $951000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 64.63%. This contributed to the annual value of $3.4 million for FY2024, which is 15920.0% up from last year.
  • As of Q3 2025, Option Care Health's Other financing activities stood at $951000.0, which was down 5480.04% from $482000.0 recorded in Q2 2025.
  • Over the past 5 years, Option Care Health's Other financing activities peaked at $7.5 million during Q4 2021, and registered a low of -$3.8 million during Q2 2023.
  • Its 5-year average for Other financing activities is $1.2 million, with a median of $1.1 million in 2024.
  • In the last 5 years, Option Care Health's Other financing activities surged by 18157.8% in 2021 and then crashed by 9528.09% in 2022.
  • Quarter analysis of 5 years shows Option Care Health's Other financing activities stood at $7.5 million in 2021, then tumbled by 95.28% to $352000.0 in 2022, then tumbled by 1165.34% to -$3.8 million in 2023, then soared by 156.11% to $2.1 million in 2024, then tumbled by 54.8% to $951000.0 in 2025.
  • Its Other financing activities was $951000.0 in Q3 2025, compared to $482000.0 in Q2 2025 and $1.9 million in Q1 2025.